Integrated Oncology Learning - Details
|
|
Online Grand Rounds: A Focus on Hematologic and Solid Tumor Malignancies A Four-Part Integrated Program
This online series is patterned after the traditional academic live format and consists of 1 module with 4 activities that address acute leukemias, early-stage breast cancer, metastatic breast cancer, and renal cell carcinoma. Each activity is a stand-alone unit comprising a 5-minute introduction and a 15-minute didactic presentation that reviews mechanisms of disease and rationale of diagnostic and therapeutic modalities that are relevant in the practice of hematology and oncology. Key recent data, commentary by the faculty, and the application of those data in defined clinical situations will be presented and discussed. The activity will end with a 10-minute question-and-answer session moderated by Dr. Steven T. Rosen. Moderated by: Presented by Physicians’ Education Resource in conjunction with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. |
Approved for [ Log in to see a status bar view of your new, in progress, and completed activities ]
A Focus on Hematologic and Solid Tumor Malignancies
Module Description & Instructions
Module Description & Instructions| Date Available | Title of Activity |
|
JUL
2009
|
Exploiting Targeted Therapies for Improved Outcomes in Renal Cell Carcinoma
Focus on current treatment options for and new data presented at national meetings in 2008-2009 on the use of antiangiogenic agents and mTOR inhibitors in patients with renal cell carcinoma
Activity Release Date: July 24, 2009
|
|
JUL
2009
|
Novel Strategies for Patients With Acute Myeloid Leukemia
Focus on new data presented at national meetings in 2008-2009 in the context of current standards, individualized application, and ongoing controversies in the management of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL)
Activity Release Date: July 31, 2009
|
|
AUG
2009
|
Chemotherapy Options in Metastatic Breast Cancer: Combination Strategies
Focus on new data presented at national meetings in 2008-2009 on combination therapy, including antiangiogenic agents and cytotoxic drugs, for patients with metastatic breast cancer
Activity Release Date: August 7, 2009
|
|
AUG
2009
|
Optimizing Endocrine Therapy and Side Effect Management for Early-Stage Breast Cancer
Focus on new data presented at national meetings in 2008-2009 on endocrine therapy, bone health, and bisphosphonates for the prevention of metastasis in patients with early-stage breast cancer
Activity Release Date: August 14, 2009
|
IOL Overview & Purpose
Grand rounds remain an integral part of medical education today and are used to not only teach residents but also ensure that staff are given up-to-date information so that they can provide patients the highest quality of care. This Online Ground Rounds series will address educational needs across the spectrum of hematology and medical oncology and provide the learner with highly focused expert updates and commentaries on current standards of therapy and evolving cancer care.
What is Integrated Oncology Learning?
A curriculum-based educational program for oncologists and hematologists from PER that is:
•Comprehensive: complete learning opportunities from a diverse team of experts
•Personalized: distinct activities in a variety of formats you can complete in any sequence
•Synergistic: modular programs consisting of related activities
•Certified: allows you to earn valuable CME credit
New to PER?
Register now for free access to Integrated Oncology Learning and other online CME activities, Email Updates, and personalized CME management!
Educational Grants
An educational grant for this Integrated Oncology Learning was provided by:
- Genentech BioOncology
- Novartis Oncology
Continuing Education Information
Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Selected activities approved for AMA PRA Category 1 Credit™
Certificates will be provided after the successful completion of each certified activity.